Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1998-9-10
pubmed:abstractText
The most striking of carboplatin's advantages (CBDCA) over cisplatin (CDDP) is its markedly reduced rate of neurotoxic effects. However, the use of CBDCA higher-intensity schedules and the association with other neurotoxic drugs in polychemotherapy may cause some concern about its safety with respect to peripheral nervous system damage.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
443-7
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9636837-Animals, pubmed-meshheading:9636837-Antineoplastic Agents, pubmed-meshheading:9636837-Behavior, Animal, pubmed-meshheading:9636837-Carboplatin, pubmed-meshheading:9636837-Cell Nucleus, pubmed-meshheading:9636837-Disease Models, Animal, pubmed-meshheading:9636837-Dose-Response Relationship, Drug, pubmed-meshheading:9636837-Female, pubmed-meshheading:9636837-Ganglia, Spinal, pubmed-meshheading:9636837-Injections, Intraperitoneal, pubmed-meshheading:9636837-Kidney, pubmed-meshheading:9636837-Liver, pubmed-meshheading:9636837-Microscopy, Electron, pubmed-meshheading:9636837-Muscles, pubmed-meshheading:9636837-Neurons, pubmed-meshheading:9636837-Organelles, pubmed-meshheading:9636837-Peripheral Nervous System Diseases, pubmed-meshheading:9636837-Random Allocation, pubmed-meshheading:9636837-Rats, pubmed-meshheading:9636837-Rats, Wistar, pubmed-meshheading:9636837-Sciatic Nerve
pubmed:year
1998
pubmed:articleTitle
Carboplatin toxic effects on the peripheral nervous system of the rat.
pubmed:affiliation
Istituto di Anatomia Umana, Università di Milano, Italy. guido.cavaletti@unimi.it
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't